SB 1638: Prohibitions Against Discriminatory Practices Relating to 340B Entities and 340B Drugs
GENERAL BILL by Jones
Prohibitions Against Discriminatory Practices Relating to 340B Entities and 340B Drugs; Prohibiting drug manufacturers from engaging in certain acts relating to the acquisition of 340B drugs by and the delivery of such drugs to specified pharmacies; prohibiting health insurance issuers, pharmacy benefit managers, and other third-party payors, and agents thereof, from engaging in certain discriminatory acts relating to reimbursement to 340B entities for 340B drugs; prohibiting individual health insurers, group, blanket, and franchise health insurers, and health maintenance organizations, respectively, and pharmacy benefit managers on behalf of such insurers and health maintenance organizations, from engaging in certain discriminatory acts relating to reimbursement to 340B entities for 340B drugs, etc.
- Banking and Insurance (BI)
- Health Policy (HP)
- Rules (RC)
Bill History
| Date | Chamber | Action |
|---|---|---|
| 1/9/2026 | Senate |
• Filed |
| 1/16/2026 | Senate |
• Referred to Banking and Insurance; Health Policy; Rules |
| 1/22/2026 | Senate |
• Introduced |